MicroPort CardioFlow Medtech Corporation
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valv… Read more
MicroPort CardioFlow Medtech Corporation (MROPF) - Total Assets
Latest total assets as of June 2025: $2.67 Billion USD
Based on the latest financial reports, MicroPort CardioFlow Medtech Corporation (MROPF) holds total assets worth $2.67 Billion USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
MicroPort CardioFlow Medtech Corporation - Total Assets Trend (2020–2024)
This chart illustrates how MicroPort CardioFlow Medtech Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
MicroPort CardioFlow Medtech Corporation - Asset Composition Analysis
Current Asset Composition (December 2024)
MicroPort CardioFlow Medtech Corporation's total assets of $2.67 Billion consist of 62.6% current assets and 37.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 4.0% |
| Accounts Receivable | $136.59 Million | 5.1% |
| Inventory | $135.38 Million | 5.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $192.28 Million | 7.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how MicroPort CardioFlow Medtech Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MicroPort CardioFlow Medtech Corporation's current assets represent 62.6% of total assets in 2024, a decrease from 64.7% in 2020.
- Cash Position: Cash and equivalents constituted 4.0% of total assets in 2024, down from 55.1% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, a decrease from 21.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 7.2% of total assets.
MicroPort CardioFlow Medtech Corporation Competitors by Total Assets
Key competitors of MicroPort CardioFlow Medtech Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
MicroPort CardioFlow Medtech Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - MicroPort CardioFlow Medtech Corporation generates 0.14x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - MicroPort CardioFlow Medtech Corporation is currently not profitable relative to its asset base.
MicroPort CardioFlow Medtech Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.94 | 7.60 | 12.82 |
| Quick Ratio | 6.50 | 7.13 | 12.17 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.46 Billion | $ 1.64 Billion | $ 2.09 Billion |
MicroPort CardioFlow Medtech Corporation - Advanced Valuation Insights
This section examines the relationship between MicroPort CardioFlow Medtech Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.04 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 3.8% |
| Total Assets | $2.68 Billion |
| Market Capitalization | $99.66 Million USD |
Valuation Analysis
Below Book Valuation: The market values MicroPort CardioFlow Medtech Corporation's assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: MicroPort CardioFlow Medtech Corporation's assets grew by 3.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for MicroPort CardioFlow Medtech Corporation (2020–2024)
The table below shows the annual total assets of MicroPort CardioFlow Medtech Corporation from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $2.68 Billion | +3.83% |
| 2023-12-31 | $2.58 Billion | -14.13% |
| 2022-12-31 | $3.00 Billion | -10.73% |
| 2021-12-31 | $3.36 Billion | +202.29% |
| 2020-12-31 | $1.11 Billion | -- |